Yayıncı "Medical Communications" Scopus İndeksli Yayınlar Koleksiyonu için listeleme
Toplam kayıt 1, listelenen: 1-1
-
Antiangiogenic therapy in ovarian cancer for whom and when?
(Medical Communications, 2017)Tumor angiogenesis appears to be an important process in epithelial ovarian cancer development. Bevacizumab is a monoclonal antibody that can neutralize vascular endothelial growth factor, a promoter of the initiation phase ...